Don’t invest unless you’re prepared to lose all the money you invest. This is a highrisk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more

The Blavatnik

Prize for Innovation

A £1m prize fund aimed at pre-investment startups, providing up to £50,000 in non-dilutive funding and guidance from the QantX team. Applicants should consider projects that unlock a commercial barrier for an innovative technology that provides a route to equity investment.

The Blavatnik Prize for Innovation is currently closed for applications.

Receiving the £25k Blavatnik prize in 2022 enabled Lutra Health to build and launch a proof of concept in the NHS. The excellent results from this NHS trial and the ongoing support from QantX have enabled Lutra to complete its pre-seed round. The round was led by QantX, whose deep sector expertise has already proven pivotal to our development. We highly recommend applying!

Charles Solanki

Co-Founder, Lutra Health